Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Free Cash Flow (2016 - 2025)

Bruker's Free Cash Flow history spans 16 years, with the latest figure at $207.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 35.16% year-over-year to $207.2 million; the TTM value through Dec 2025 reached $43.3 million, down 68.16%, while the annual FY2025 figure was $43.3 million, 68.16% down from the prior year.
  • Free Cash Flow reached $207.2 million in Q4 2025 per BRKRP's latest filing, up from -$54.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $207.2 million in Q4 2025 to a low of -$148.8 million in Q2 2025.
  • Average Free Cash Flow over 5 years is $37.9 million, with a median of $14.5 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: crashed 8800.0% in 2022, then soared 9650.0% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $110.2 million in 2021, then rose by 24.23% to $136.9 million in 2022, then rose by 27.1% to $174.0 million in 2023, then dropped by 11.9% to $153.3 million in 2024, then soared by 35.16% to $207.2 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Free Cash Flow are $207.2 million (Q4 2025), -$54.1 million (Q3 2025), and -$148.8 million (Q2 2025).